Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/28/1995 | WO1995035289A1 Novel amido quinoxaline diones, their production and use |
12/28/1995 | WO1995035287A1 N,n'-bis(quinolin-4-yl)-diamine derivatives, their preparation and their use as antimalarials |
12/28/1995 | WO1995035286A1 New hiv protease inhibitors |
12/28/1995 | WO1995035284A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
12/28/1995 | WO1995035283A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
12/28/1995 | WO1995035281A1 Tri-substituted phenyl derivates useful as pde iv inhibitors |
12/28/1995 | WO1995035279A1 Substituted alkyldiamine derivatives and their use as tachykinin antagonists |
12/28/1995 | WO1995035277A1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
12/28/1995 | WO1995035276A1 Metalloproteinase inhibitors |
12/28/1995 | WO1995035275A1 Metalloproteinase inhibitors |
12/28/1995 | WO1995035112A2 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
12/28/1995 | WO1995035111A2 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION |
12/28/1995 | WO1995035110A1 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
12/28/1995 | WO1995035109A1 A method for treating pain and brain perfusion abnormalities |
12/28/1995 | WO1995035108A1 Thiazolidine derivatives for the treatment of psoriasis |
12/28/1995 | WO1995035107A1 Endothelin receptor antagonists |
12/28/1995 | WO1995035106A1 Hiv growth inhibitory composition |
12/28/1995 | WO1995035105A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
12/28/1995 | WO1995035104A1 Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
12/28/1995 | WO1995035103A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
12/28/1995 | WO1995035102A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
12/28/1995 | WO1995035099A1 Vitamin/nutrient dosage regimentation |
12/28/1995 | WO1995035096A1 Controlled release aqueous emulsion |
12/28/1995 | WO1995035086A1 Composition and treatment for baldness |
12/28/1995 | WO1995032203A3 Use of tetrahydropteridine derivatives as no-synthase inhibitors |
12/28/1995 | WO1995029917A3 Intermediates in pharmaceutical camptothecin preparation |
12/28/1995 | CA2193732A1 Novel amido quinoxaline diones, their production and use |
12/28/1995 | CA2193692A1 Metalloproteinase inhibitors |
12/28/1995 | CA2193691A1 Metalloproteinase inhibitors |
12/28/1995 | CA2193645A1 Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
12/28/1995 | CA2193644A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
12/28/1995 | CA2193530A1 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
12/28/1995 | CA2193496A1 Antiviral agent containing benzodithiin derivative as active ingredient |
12/28/1995 | CA2193396A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
12/28/1995 | CA2193362A1 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
12/28/1995 | CA2193239A1 Hiv growth inhibitory composition |
12/28/1995 | CA2193220A1 New hiv protease inhibitors |
12/28/1995 | CA2193205A1 High-affinity melatonin receptors and uses thereof |
12/28/1995 | CA2193133A1 Novel thrombin inhibitors, the preparation and use thereof |
12/28/1995 | CA2193100A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
12/28/1995 | CA2193086A1 Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors |
12/28/1995 | CA2192950A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
12/28/1995 | CA2192938A1 A method for treating pain and brain perfusion abnormalities |
12/28/1995 | CA2192827A1 Use of .beta.galnac(1-4).beta.gal conjugates to treat candida infection |
12/28/1995 | CA2192203A1 N,n'-bis(quinolin-4-yl)-diamine derivatives, their preparation and their use as antimalarials |
12/28/1995 | CA2191455A1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
12/28/1995 | CA2169050A1 Indol derivatives useful for the treatment of migraine, composition and utilization |
12/28/1995 | CA2165956A1 Novel substituted purinyl derivatives with immunomodulating activity |
12/28/1995 | CA2152420A1 Therapeutic agent for the treatment of xerostomia |
12/28/1995 | CA2151335A1 Non-reducing saccharide and its production and use |
12/28/1995 | CA2150888A1 Powder preparation for healing damaged skin |
12/27/1995 | EP0688874A2 Nucleic acid fragments and diagnostic reagents derived from the genome of HHV6/SIE and diagnostic procedures for HHV6 infections |
12/27/1995 | EP0688866A1 Thermostable trehalose-releasing enzyme, and its preparation and uses |
12/27/1995 | EP0688787A1 Medicinal composition for bone resorption inhibition and osteogenesis acceleration |
12/27/1995 | EP0688786A1 New hydrazino and hydroxyamino-14beta-hydroxyandrostane derivatives active on the cardio-vascular system, processes for their preparation and pharmaceutical compositions containing same |
12/27/1995 | EP0688784A2 3'-Modified oligonucleotide derivatives |
12/27/1995 | EP0688783A1 Method for preparing 2',deoxy-2',2'-difluornucleosides |
12/27/1995 | EP0688782A1 Stereoselective process for preparing protected 2',2'-difluorolactonen |
12/27/1995 | EP0688775A1 Method for the purification of 23 -E isomers of 23-imino derivatives of LL-F28249 compounds |
12/27/1995 | EP0688772A1 Novel quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation |
12/27/1995 | EP0688771A1 Use of lactam compounds as pharmaceutical agents |
12/27/1995 | EP0688766A1 Phenylsubstituted alkenyl-carboxylic-acid-guanidines containing perfluoroalkyl groups, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them |
12/27/1995 | EP0688761A2 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
12/27/1995 | EP0688565A1 Tablet, capsule, or granule comprising desogestrel |
12/27/1995 | EP0688559A1 Skin anti-ageing composition |
12/27/1995 | EP0688357A1 Eye care products containing a pheromone additive and method of using the same |
12/27/1995 | EP0688337A1 Compositions and methods for the treatment of immunomediated inflammatory disorders |
12/27/1995 | EP0688333A1 Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants |
12/27/1995 | EP0688331A1 New sulfated lyso-ganglioside derivatives |
12/27/1995 | EP0688330A1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
12/27/1995 | EP0688325A1 Phosphonic acid derivatives |
12/27/1995 | EP0688324A1 Novel 3-(substituted methyl)-4-oxa-1-azabicyclo 3.2.0]heptan-7-one derivatives useful as antitumor agents |
12/27/1995 | EP0688320A1 Tricyclic benzodiazepins, their use and preparation |
12/27/1995 | EP0688319A1 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
12/27/1995 | EP0688315A1 New heterocyclic compounds, their preparation and their use |
12/27/1995 | EP0688314A1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use |
12/27/1995 | EP0688313A1 Ligands and metal complexes thereof |
12/27/1995 | EP0688312A1 New derivatives of glutamic acid, a method of preparing them, and their use as drugs for enhancing memory and learning |
12/27/1995 | EP0688222A1 Therapeutic compositions containing a lithium compound and silica |
12/27/1995 | EP0688221A1 Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
12/27/1995 | EP0688220A1 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
12/27/1995 | EP0688219A1 Reduction of boar odor in meat |
12/27/1995 | EP0688218A1 Interleukin-1 inhibitor |
12/27/1995 | EP0688217A1 Heterocycle-containing macrocyclic immunomodulators |
12/27/1995 | EP0688216A1 Medicament for treating or preventing cerebrovascular diseases |
12/27/1995 | EP0688215A1 3,4-diarylchromans for treatment of dermatitis |
12/27/1995 | EP0688214A1 Methods for inhibiting bone loss with 3,4-diarylchroman |
12/27/1995 | EP0688213A1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity |
12/27/1995 | EP0688212A1 C9 taxane derivatives and pharmaceutical compositions containing them |
12/27/1995 | EP0688211A1 Methods and compositions for inhibition of angiogenesis |
12/27/1995 | EP0688210A1 Use of carnosine or a combination with urocanic acid for treatment of photodermatoses |
12/27/1995 | EP0688209A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
12/27/1995 | EP0688208A1 Sugar- and sodium-free effervescent tablets and granules and process for preparing same |
12/27/1995 | EP0688204A1 Composition and method for whitening skin |
12/27/1995 | EP0688167A1 Ionene polymers as microbicides |
12/27/1995 | EP0644754A4 Substance that can stop bleeding in surgical, medical and dental uses/substance powder 001 that can stop bleeding during surgery, after surgery, medicine, dentistry or any bleeding due to any causes. |
12/27/1995 | EP0607178A4 Methods for the selection, separation and fusion of cells. |
12/27/1995 | EP0584159B1 Nutrient preparation |
12/27/1995 | EP0579646B1 Anti-cancer antracene derivatives |
12/27/1995 | EP0575442B1 Tetracyclic imidazoquinazoline derivatives, process for their preparation and pharmaceutical compositions containing them |